Home › Immunoglobulin Light-chain Amyloidosis › North Carolina
Immunoglobulin Light-chain Amyloidosis clinical trials in North Carolina
4 studies for Immunoglobulin Light-chain Amyloidosis are looking for participants at sites in North Carolina.
Cities in North Carolina
Registry of Older Patients With Cancer
- Seby B. Jones Cancer Center, Boone
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
- East Carolina University, Greenville
- and 4 more
RecruitingObservational study
Ages 65 and older · All sexes · Updated Jun 29, 2026 · NCT01137825Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- Novant Health Presbyterian Medical Center, Charlotte
- Duke University Medical Center, Durham
- Novant Health Cancer Institute - Huntersville, Huntersville
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06022939Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Oct 27, 2025 · NCT01137643Screening for AL Amyloidosis in Smoldering Multiple Myeloma
- Atrium Health Levine Cancer Institute, Charlotte
- UNC Lineberger Comprehensive Cancer Center, Durham
RecruitingObservational study
Ages 40 and older · All sexes · Updated Aug 6, 2025 · NCT06365060From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.